SG10201608753UA - Injectable preparation - Google Patents
Injectable preparationInfo
- Publication number
- SG10201608753UA SG10201608753UA SG10201608753UA SG10201608753UA SG10201608753UA SG 10201608753U A SG10201608753U A SG 10201608753UA SG 10201608753U A SG10201608753U A SG 10201608753UA SG 10201608753U A SG10201608753U A SG 10201608753UA SG 10201608753U A SG10201608753U A SG 10201608753UA
- Authority
- SG
- Singapore
- Prior art keywords
- injectable preparation
- injectable
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261636938P | 2012-04-23 | 2012-04-23 | |
US201361792089P | 2013-03-15 | 2013-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201608753UA true SG10201608753UA (en) | 2016-12-29 |
Family
ID=48614096
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201608753UA SG10201608753UA (en) | 2012-04-23 | 2013-04-23 | Injectable preparation |
SG10201913425VA SG10201913425VA (en) | 2012-04-23 | 2013-04-23 | Injectable preparation |
SG11201406451SA SG11201406451SA (en) | 2012-04-23 | 2013-04-23 | Injectable preparation |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201913425VA SG10201913425VA (en) | 2012-04-23 | 2013-04-23 | Injectable preparation |
SG11201406451SA SG11201406451SA (en) | 2012-04-23 | 2013-04-23 | Injectable preparation |
Country Status (32)
Country | Link |
---|---|
US (8) | US20150093442A1 (en) |
EP (2) | EP3539534A1 (en) |
JP (6) | JP6234996B2 (en) |
KR (4) | KR20240068788A (en) |
CN (3) | CN114344259B (en) |
AR (1) | AR090776A1 (en) |
AU (5) | AU2013253374B2 (en) |
BR (1) | BR112014026307B1 (en) |
CA (2) | CA2869889C (en) |
CO (1) | CO7151500A2 (en) |
CY (1) | CY1122252T1 (en) |
DK (1) | DK2841054T4 (en) |
EA (1) | EA026619B1 (en) |
ES (1) | ES2743706T5 (en) |
HK (2) | HK1206988A1 (en) |
HR (1) | HRP20191366T4 (en) |
HU (1) | HUE045979T2 (en) |
IL (1) | IL235299B (en) |
JO (2) | JOP20200109A1 (en) |
LT (1) | LT2841054T (en) |
MX (1) | MX359241B (en) |
MY (2) | MY198007A (en) |
NZ (1) | NZ630335A (en) |
PH (2) | PH12014502379B1 (en) |
PL (1) | PL2841054T5 (en) |
PT (1) | PT2841054T (en) |
SG (3) | SG10201608753UA (en) |
SI (1) | SI2841054T2 (en) |
TW (4) | TW202126303A (en) |
UA (1) | UA115444C2 (en) |
WO (1) | WO2013162048A1 (en) |
ZA (1) | ZA201407335B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR090775A1 (en) * | 2012-04-23 | 2014-12-03 | Otsuka Pharma Co Ltd | INJECTABLE PREPARATION |
TWI562991B (en) * | 2012-04-23 | 2016-12-21 | Otsuka Pharma Co Ltd | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same |
JOP20200109A1 (en) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | Injectable preparation |
CN105461703B (en) * | 2014-12-29 | 2019-05-17 | 深圳市泛谷药业股份有限公司 | A kind of preparation method of brexpiprazole |
JP6513461B2 (en) * | 2015-04-14 | 2019-05-15 | 帝國製薬株式会社 | Transdermal preparation of brexpiprazole |
CN104829603A (en) * | 2015-05-19 | 2015-08-12 | 杭州新博思生物医药有限公司 | Crystal form A brexpiprazole hydrochloride and preparation method thereof |
US10501450B2 (en) | 2016-02-01 | 2019-12-10 | Hexal Ag | Anhydrate-free polymorphically pure micronized crystalline brexpiprazole di-hydrate for use in intramuscular injectable sustained release formulations |
US11235976B2 (en) * | 2017-01-26 | 2022-02-01 | Sichuan Yingrui Pharmaceutical Technology Company | Nanocarbon-iron composite system as well as composition, preparation method and use thereof |
WO2019213286A1 (en) * | 2018-05-02 | 2019-11-07 | LifeMax Laboratories, Inc. | Extended release suspension formulation of lurasidone |
US20210401775A1 (en) * | 2018-11-02 | 2021-12-30 | Amaterasu Lifesciences Llp | A liquid injectable composition |
WO2021199076A1 (en) * | 2020-03-30 | 2021-10-07 | Cipla Limited | Injectable aripiprazole formulation |
CN115397420A (en) | 2020-04-01 | 2022-11-25 | 大塚制药株式会社 | Dose initiation method for aripiprazole therapy |
WO2022093722A1 (en) * | 2020-10-27 | 2022-05-05 | Pts Consulting, Llc | A liquid injectable composition of donepezil |
US11229644B1 (en) * | 2020-12-31 | 2022-01-25 | Lake O'hara Llc | Methods of treating psychiatric disorders in obese patients with brexpiprazole |
US11910794B2 (en) * | 2021-03-08 | 2024-02-27 | Monsanto Technology Llc | Solutions and methods for long-term pollen storage |
WO2023067664A1 (en) * | 2021-10-18 | 2023-04-27 | 大塚製薬株式会社 | Novel crystal form of benzothiophene compound and production method therefor |
JP2024526422A (en) * | 2022-06-16 | 2024-07-18 | ウィズダム・ファーマスーティカル・カンパニー・リミテッド | Drug composition and brexpiprazole oral dissolving film |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB864100A (en) * | 1957-04-09 | 1961-03-29 | Pfizer & Co C | Therapeutic pencillin compositions and the preparation thereof |
JPS5913714A (en) | 1982-07-13 | 1984-01-24 | Taito Pfizer Kk | Antiphlogistic and analgesic agent for external use |
US5006528A (en) | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
US5192802A (en) | 1991-09-25 | 1993-03-09 | Mcneil-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
JP4012994B2 (en) | 1996-05-08 | 2007-11-28 | 大塚製薬株式会社 | Anxiolytic |
US20020076437A1 (en) | 2000-04-12 | 2002-06-20 | Sanjeev Kothari | Flashmelt oral dosage formulation |
US6495164B1 (en) | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
AR032641A1 (en) | 2001-01-29 | 2003-11-19 | Otsuka Pharma Co Ltd | RECEIVER SUBTIPE AGONIST 5-HT 1A. |
MY129350A (en) | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
PE20030445A1 (en) * | 2001-09-25 | 2003-07-26 | Otsuka Pharma Co Ltd | ARIPIPRAZOLE MEDICINAL SUBSTANCE OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME |
AR033485A1 (en) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | MEDICINAL SUBSTANCE OF ARIPIPRAZOL OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME |
JP2003171264A (en) * | 2001-12-07 | 2003-06-17 | Taiyo Yakuhin Kogyo Kk | Microcapsule and method for producing the same |
JP2003238393A (en) | 2002-02-15 | 2003-08-27 | Otsuka Pharmaceut Co Ltd | Tablet with improved tableting property and method for producing the same |
RU2342931C2 (en) | 2002-08-20 | 2009-01-10 | Бристол-Маерс Сквибб Компани | Compound on basis of aripiprazole complex |
NZ540054A (en) | 2002-12-27 | 2007-09-28 | Otsuka Pharma Co Ltd | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
SI1480953T2 (en) | 2003-01-09 | 2010-12-31 | Otsuka Pharma Co Ltd | Process for preparing aripiprazole |
US7658998B2 (en) | 2003-01-22 | 2010-02-09 | Alkermes Controlled Therapeutics, Inc. | Method of preparing sustained release microparticles |
US20070110784A1 (en) * | 2003-05-02 | 2007-05-17 | Rimon Therapeutics Ltd. | Thermally reversible implant |
LT1626721T (en) | 2003-05-23 | 2017-01-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and mood stabilizers for treating mood disorders |
US6987111B2 (en) | 2003-08-06 | 2006-01-17 | Alkermes Controlled Therapeutics, Ii | Aripiprazole, olanzapine and haloperidol pamoate salts |
US20050032811A1 (en) | 2003-08-06 | 2005-02-10 | Josiah Brown | Methods for administering aripiprazole |
CN1870980B (en) | 2003-10-23 | 2010-06-23 | 大冢制药株式会社 | Controlled release sterile injectable aripiprazole formulation and method |
TWI371274B (en) | 2003-10-23 | 2012-09-01 | Bristol Myers Squibb Co | Process for making sterile aripiprazole of desired mean particle size |
JP2007509954A (en) | 2003-10-27 | 2007-04-19 | ダウ コーニング コーポレーション | Sustained release compositions for topical application and methods of delivering active agents to a substrate |
EP1711124A4 (en) * | 2004-01-12 | 2011-06-01 | Univ Pennsylvania | Long-term delivery formulations and methods of use thereof |
JP2006219380A (en) * | 2005-02-08 | 2006-08-24 | Minofuaagen Seiyaku:Kk | Glycyrrhizin subcutaneous injection preparation |
TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
EP1933814A2 (en) | 2005-09-15 | 2008-06-25 | Elan Pharma International Limited | Nanoparticulate aripiprazole formulations |
CN101309713A (en) | 2005-11-17 | 2008-11-19 | 周吉尼克斯股份有限公司 | Viscous formulations and their use in needle-free injection |
JP4373983B2 (en) | 2006-01-27 | 2009-11-25 | 三菱電機インフォメーションシステムズ株式会社 | Distribution channel management device and distribution channel management program |
GB0618879D0 (en) * | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
WO2008041245A2 (en) * | 2006-10-05 | 2008-04-10 | Panacea Biotec Ltd. | Injectable depot composition and it's process of preparation |
JP4540700B2 (en) | 2006-10-13 | 2010-09-08 | 大塚製薬株式会社 | Medicine |
WO2008090632A1 (en) | 2007-01-26 | 2008-07-31 | Otsuka Pharmaceutical Co., Ltd. | Marker for detecting the proposed efficacy of treatment |
WO2009001697A2 (en) | 2007-06-25 | 2008-12-31 | Otsuka Pharmaceutical Co., Ltd. | Microspheres having core/shell structure |
HUE036214T2 (en) * | 2007-07-31 | 2018-06-28 | Otsuka Pharma Co Ltd | Methods for producing aripiprazole suspension and freeze-dried formulation |
WO2009026473A2 (en) * | 2007-08-21 | 2009-02-26 | Hollis-Eden Pharmaceuticals, Inc. | Stabilized therapeutic compositions and formulations |
JP2011136906A (en) * | 2008-04-18 | 2011-07-14 | Otsuka Pharmaceut Co Ltd | Heterocyclic compound |
JP2009286740A (en) | 2008-05-30 | 2009-12-10 | Otsuka Pharmaceut Co Ltd | Reverse tolerance inhibitor containing aripiprazole |
TR200809200A1 (en) * | 2008-12-01 | 2009-12-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Pharmaceutical formulations containing meloxicam |
CA2763456C (en) | 2009-05-27 | 2017-10-24 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
BR112012005401A2 (en) | 2009-09-11 | 2017-02-21 | Otsuka Pharma Co Ltd | therapeutic agent for chronic pain |
MX344235B (en) * | 2010-08-24 | 2016-12-07 | Otsuka Pharmaceutical Co Ltd * | Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative. |
US9469630B2 (en) * | 2010-10-18 | 2016-10-18 | Sumitomo Dainippon Pharma Co., Ltd. | Sustained-release formulation for injection |
AR083884A1 (en) | 2010-11-16 | 2013-03-27 | Otsuka Pharma Co Ltd | DOUBLE CHAMBER AND FILLING SYRINGE OF ARIPIPRAZOL IN THE SYRINGE |
JP2012121850A (en) | 2010-12-09 | 2012-06-28 | Otsuka Pharmaceut Co Ltd | Oral fast-dissolving composition of aripiprazole |
EP2667856B9 (en) | 2011-01-24 | 2021-12-01 | Otsuka Pharmaceutical Co., Ltd. | Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient |
AR085840A1 (en) | 2011-04-05 | 2013-10-30 | Otsuka Pharma Co Ltd | MEDICINAL PRODUCT CONTAINING A COMPOUND THAT IS 7- [4- (4-BENZO [B] TIOFEN-4-IL-PIPERAZIN-1-IL) BUTOXI] -1H-QUINOLIN-2-ONA |
JP2012232958A (en) | 2011-05-09 | 2012-11-29 | Otsuka Pharmaceut Co Ltd | Injection preparation |
JO3410B1 (en) | 2011-06-07 | 2019-10-20 | Otsuka Pharma Co Ltd | Freeze-dried aripiprazole formulation |
CN102846543B (en) * | 2011-06-27 | 2014-11-19 | 上海中西制药有限公司 | Aripiprazole pharmaceutic preparation and preparation method thereof |
TW201309651A (en) | 2011-06-29 | 2013-03-01 | Otsuka Pharma Co Ltd | Method for producing fine particles of aripiprazole anhydride crystals B |
TWI546299B (en) | 2011-07-28 | 2016-08-21 | 大塚製藥股份有限公司 | Method for producing benzo[b]thiophene compound |
JO3227B1 (en) | 2011-09-08 | 2018-03-08 | Otsuka Pharma Co Ltd | Piperazine-substituted benzothiophene deriveatives as antipsychotic agents |
JO3753B1 (en) | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof |
JO3190B1 (en) | 2011-10-19 | 2018-03-08 | Otsuka Pharma Co Ltd | Solution for oral administration |
TW201332572A (en) | 2011-12-28 | 2013-08-16 | Otsuka Pharma Co Ltd | Pharmaceutical preparation comprising substituted β -cyclodextrin |
JP2013139441A (en) | 2011-12-28 | 2013-07-18 | Otsuka Pharmaceut Co Ltd | Microsphere |
AR090245A1 (en) | 2012-03-06 | 2014-10-29 | Otsuka Pharma Co Ltd | ORAL SOLID PREPARATION OF SUSTAINED RELEASE, PREPARATION METHOD |
TWI562991B (en) | 2012-04-23 | 2016-12-21 | Otsuka Pharma Co Ltd | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same |
AR090775A1 (en) | 2012-04-23 | 2014-12-03 | Otsuka Pharma Co Ltd | INJECTABLE PREPARATION |
JOP20200109A1 (en) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | Injectable preparation |
-
2012
- 2012-04-23 JO JOP/2020/0109A patent/JOP20200109A1/en unknown
-
2013
- 2013-04-22 AR ARP130101321A patent/AR090776A1/en not_active Application Discontinuation
- 2013-04-23 UA UAA201411954A patent/UA115444C2/en unknown
- 2013-04-23 DK DK13728542.5T patent/DK2841054T4/en active
- 2013-04-23 CA CA2869889A patent/CA2869889C/en active Active
- 2013-04-23 US US14/396,380 patent/US20150093442A1/en not_active Abandoned
- 2013-04-23 MY MYPI2018001894A patent/MY198007A/en unknown
- 2013-04-23 KR KR1020247015029A patent/KR20240068788A/en not_active Application Discontinuation
- 2013-04-23 SI SI201331550T patent/SI2841054T2/en unknown
- 2013-04-23 SG SG10201608753UA patent/SG10201608753UA/en unknown
- 2013-04-23 BR BR112014026307-8A patent/BR112014026307B1/en active IP Right Grant
- 2013-04-23 CA CA3120297A patent/CA3120297A1/en active Pending
- 2013-04-23 JO JOP/2013/0116A patent/JO3632B1/en active
- 2013-04-23 KR KR1020217029406A patent/KR20210116702A/en not_active Application Discontinuation
- 2013-04-23 WO PCT/JP2013/062683 patent/WO2013162048A1/en active Application Filing
- 2013-04-23 TW TW109130917A patent/TW202126303A/en unknown
- 2013-04-23 ES ES13728542T patent/ES2743706T5/en active Active
- 2013-04-23 CN CN202210169142.5A patent/CN114344259B/en active Active
- 2013-04-23 HU HUE13728542A patent/HUE045979T2/en unknown
- 2013-04-23 AU AU2013253374A patent/AU2013253374B2/en active Active
- 2013-04-23 CN CN201810143716.5A patent/CN108186556B/en active Active
- 2013-04-23 EP EP19169193.0A patent/EP3539534A1/en active Pending
- 2013-04-23 MY MYPI2014002932A patent/MY178573A/en unknown
- 2013-04-23 KR KR1020147032714A patent/KR102138852B1/en active IP Right Grant
- 2013-04-23 MX MX2014012811A patent/MX359241B/en active IP Right Grant
- 2013-04-23 EP EP13728542.5A patent/EP2841054B2/en active Active
- 2013-04-23 EA EA201491685A patent/EA026619B1/en not_active IP Right Cessation
- 2013-04-23 CN CN201380021440.9A patent/CN104470499B/en active Active
- 2013-04-23 LT LTEP13728542.5T patent/LT2841054T/en unknown
- 2013-04-23 KR KR1020207015451A patent/KR102498075B1/en active IP Right Grant
- 2013-04-23 TW TW102114410A patent/TWI637752B/en active
- 2013-04-23 JP JP2015506529A patent/JP6234996B2/en active Active
- 2013-04-23 SG SG10201913425VA patent/SG10201913425VA/en unknown
- 2013-04-23 TW TW111116460A patent/TW202313036A/en unknown
- 2013-04-23 TW TW107109282A patent/TWI713826B/en active
- 2013-04-23 PT PT13728542T patent/PT2841054T/en unknown
- 2013-04-23 NZ NZ630335A patent/NZ630335A/en unknown
- 2013-04-23 PL PL13728542.5T patent/PL2841054T5/en unknown
- 2013-04-23 SG SG11201406451SA patent/SG11201406451SA/en unknown
- 2013-04-23 HR HRP20191366TT patent/HRP20191366T4/en unknown
-
2014
- 2014-10-09 ZA ZA2014/07335A patent/ZA201407335B/en unknown
- 2014-10-23 IL IL235299A patent/IL235299B/en active IP Right Grant
- 2014-10-23 PH PH12014502379A patent/PH12014502379B1/en unknown
- 2014-11-21 CO CO14256422A patent/CO7151500A2/en unknown
-
2015
- 2015-08-08 HK HK15107658.1A patent/HK1206988A1/en active IP Right Maintenance
-
2017
- 2017-09-11 US US15/701,202 patent/US20180055941A1/en not_active Abandoned
- 2017-09-14 AU AU2017228608A patent/AU2017228608C1/en active Active
- 2017-10-25 JP JP2017206658A patent/JP6470378B2/en active Active
-
2018
- 2018-10-10 US US16/156,958 patent/US10517951B2/en active Active
- 2018-12-17 HK HK18116152.0A patent/HK1257028A1/en unknown
-
2019
- 2019-01-07 AU AU2019200060A patent/AU2019200060A1/en not_active Abandoned
- 2019-01-16 JP JP2019005031A patent/JP2019070028A/en active Pending
- 2019-03-07 PH PH12019500498A patent/PH12019500498A1/en unknown
- 2019-07-17 US US16/514,973 patent/US20190336607A1/en not_active Abandoned
- 2019-08-28 CY CY20191100912T patent/CY1122252T1/en unknown
-
2020
- 2020-02-07 US US16/785,268 patent/US20200179517A1/en not_active Abandoned
- 2020-06-24 AU AU2020204200A patent/AU2020204200B2/en active Active
- 2020-10-14 JP JP2020172902A patent/JP2021008512A/en active Pending
- 2020-12-01 US US17/108,939 patent/US11097007B2/en active Active
-
2021
- 2021-08-04 US US17/444,469 patent/US11638757B2/en active Active
-
2022
- 2022-01-14 JP JP2022004098A patent/JP7293412B2/en active Active
- 2022-09-27 AU AU2022241491A patent/AU2022241491A1/en active Pending
- 2022-12-30 US US18/148,860 patent/US12016927B2/en active Active
-
2023
- 2023-06-06 JP JP2023092924A patent/JP2023113806A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1257028A1 (en) | Injectable preparation | |
DK3327112T3 (en) | Agse-deficient stamme | |
GB201210082D0 (en) | Improved syringe | |
EP2934531A4 (en) | Combination | |
EP2754580A4 (en) | Dumptruck | |
DK2830816T3 (en) | Hidtil ukendt coatingkoncept | |
HRP20190841T1 (en) | Injectable formulation | |
EP2911673A4 (en) | Combination | |
HK1204551A1 (en) | Injectable compositions | |
EP2920142A4 (en) | Methanofullerenes | |
ZA201406703B (en) | Improved injections | |
EP2812698A4 (en) | Dual-acceptor time-resolved-fret | |
EP2873363A4 (en) | Diopsimeter | |
GB2500883B (en) | Improved saw-horse | |
EP2834250A4 (en) | Lithiumsilicate | |
EP2925728A4 (en) | Combination | |
GB201210088D0 (en) | Odontalgic preparation | |
EP2908816A4 (en) | Combination | |
EP2908815A4 (en) | Combination | |
ZA201305187B (en) | Improved brattice | |
GB201216178D0 (en) | Combination | |
AU345893S (en) | Treehouse |